DNTH: Dianthus Therapeutics Company Short-Term Debt
Dianthus Therapeutics (DNTH) utilizes software algorithms to develop anti-inflammatory agents, although final human trials require medical supervision. This daily price chart demonstrates the asset's dynamics, where the indicator stands at 0.00. Protein synthesis stability is ensured by the timely upgrading of external contractors' equipment, while overall business efficiency is based on the operation of leading US R&D centers with full production outsourcing.
Metric breakdowns and analytics for Dianthus Corp (DNTH)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Dianthus Therapeutics|DNTH - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Dianthus Therapeutics|DNTH - Company Total Debt|Debt to Book Capitalization Ratio Dianthus Therapeutics, Inc.|DNTH - Company Long-Term Liabilities|Company Current Liabilities Dianthus Therapeutics|Quick Liquidity dianthustx.com
- net income and valuation multiples indicators:
Initial company analysis:DNTH - Dianthus Therapeutics, Inc.
Short-term debts reflect the total obligations with a maturity of up to one year, determining the risk of cash flow gaps. This metric measures management's ability to maintain liquidity without sharp spikes in debt. By analyzing the history of short-term debt changes, an investor sees the current value of 0.00. A stable debt level confirms the financial discipline of the Dianthus Therapeutics (DNTH) leadership. This allows the company to effectively finance accelerated clinical trials of innovative drugs.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|Company Current Liabilities ABCL|Company Short-Term Debts Tourmaline|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|Zenas Biopharma, Inc. - Company Short-Term Debts|IMNM (Immunome Bio) - Company Short-Term Indebtedness|GOSS: Company Short-Term Debts|KALV - Short-Term Debt Volume|SEPN (Septerna) - Company Short-Term Debts|Company Short-Term Debts Pieris Pharma|Company Short-Term Debt Savara Corp (SVRA)|Rigel Corp - Company Short-Term Indebtedness|AnaptysBio, Inc. - Company Current Liabilities|Amount of Current Liabilities ATXS (astriatx.com)|enGene - Company Short-Term Debts|Company Short-Term Loans and Borrowings RAPT (rapt.com)|JBIO (aerovatetx.com) - Company Current Liabilities|Aclaris Therapeutics, Inc (ACRS) - Company Short-Term Debts|Company Short-Term Debt Kyverna Therapeutics|tizianalifesciences.com (TLSA) - Short-Term Debt Volume|Company Current Liabilities CABA (Cabaletta Bio)|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Theratechnologies Inc - Company Current Liabilities|Amount of Current Liabilities AVTX (Avalo Therapeutics Inc)|Eledon Pharmaceuticals - Company Short-Term Debts|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|CLYM: Company Short-Term Debts|Short-Term Debt zurabio.com (ZURA)|Company Short-Term Debt aTyr|ADAG: Company Short-Term Loans and Borrowings|Company Short-Term Debts IMA|Company Short-Term Debts shattucklabs.com (STTK)|Company Short-Term Debt Equillium EQ|CNTB (Connect Biopharma Holdings) - Current Liabilities|Immunic Inc - Company Short-Term Debts|Short-Term Debt Atara Biotherapeutics|IFRX (inflarx.de) - Company Current Liabilities|x4pharma.com (XFOR) - Company Short-Term Debts|Company Current Liabilities ACET|CELU (Celularity Corp) - Amount of Current Liabilities|Company Short-Term Debts INMB|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debts KZR (Kezar Life Sciences)|SABS - Company Current Liabilities|AKTX - Company Short-Term Debt|Short-Term Debt Volume Enlivex Therapeutics ENLV|QTTB: Company Short-Term Debts|Company Short-Term Indebtedness GOVX|Company Short-Term Debt Edesa Biotech, Inc.|Company Short-Term Indebtedness IBIO (ibioinc.com)|Company Current Liabilities CARM (Carisma Therapeutics)|Amount of Current Liabilities XTLB|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Loans and Borrowings HCWB|APVO - Company Short-Term Debt|Current Liabilities AIM|ADTX: Company Short-Term Debts|GRI Bio Inc - Company Short-Term Loans and Borrowings|XRTX (XORTX) - Company Short-Term Debts|Company Short-Term Debts Vyome Therapeutics|Company Short-Term Debt Revelation Biosciences (REVB)|INDP (indaptusrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|CALI - Company Current Liabilities|Affimed Therapeutics - Company Short-Term Debts|ALLK - Company Short-Term Debts|HOOK (hookipapharma.com) - Company Current Liabilities|IGM Biosciences - Company Short-Term Loans and Borrowings|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|Ocean Biomedical Inc (OCEA) - Short-Term Debt Volume|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD